MARA Holdings
MARA
MicroStrategy
MSTR
Coinbase
COIN
Meta Platforms
META
Ecopetrol
EC
US Stock MarketDetailed Quotes
CARM Carisma Therapeutics
- 0.441
- +0.022+5.18%
Trading Jan 2 10:10 ET
18.39MMarket Cap-0.29P/E (TTM)
0.447High0.400Low62.09KVolume0.400Open0.419Pre Close26.07KTurnover0.21%Turnover RatioLossP/E (Static)41.75MShares2.94052wk High-1.66P/B13.31MFloat Cap0.38052wk Low--Dividend TTM30.22MShs Float51.357Historical High--Div YieldTTM11.10%Amplitude0.380Historical Low0.419Avg Price1Lot Size
About Carisma Therapeutics Company
Carisma Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of immunotherapies. It offers chimeric antigen receptor (CAR)-macrophages, a cell therapy platform focusing on the treatment of solid tumors. The company was founded by Michael Klichinsky and Saar Gill in April 2016 and is headquartered in Philadelphia, PA.
Company Profile
SymbolCARM
Company NameCarisma Therapeutics
Listing DateFeb 6, 2014
Founded2016
CEOMr. Steven Kelly
MarketNASDAQ
Employees107
Fiscal Year Ends12-31
Address3675 Market Street,Suite 200
CityPhiladelphia
ProvincePennsylvania
CountryUnited States of America
Zip Code19104
Websitehttp://carismatx.com
Company Executives
- Name
- Position
- Salary
- Steven Kelly
- Director, President and Chief Executive Officer
- 3.50M
- Richard S. Morris, C.P.A.
- Chief Financial Officer
- 1.66M
- Dr. Michael Klichinsky, PhD,Pharm.D.
- Chief Scientific Officer
- 1.60M
- Sanford S. Zweifach
- Chairman of the Board
- 271.55K
- Sohanya Roshan Cheng, M.B.A.
- Director
- --
- Dr. David T. Scadden, M.D.
- Director
- --
- Marella Thorell
- Director
- --
- Dr. John A. Hohneker, M.D.
- Independent Director
- --
- Dr. Briggs W. Morrison, M.D.
- Independent Director
- 220.20K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.